The IDMP data standards aim to standardise the submission of data on medicinal products. Remco Munnik, Associate Director at Iperion, has been working with the EU focus group creating the EU IDMP Implementation Guide version 2, published late February. He explains why pharma companies need to act now in response to the new guidance and provides practical recommendations for action.
The EU Identification of Medicinal Products (IDMP) Implementation Guide version 2.0 (EU IG), for the submission of data on medicinal products, sets out the implementation requirements of the ISO IDMP standards in the EU and triggers the countdown to the implementation of IDMP in Europe. With the clock ticking, life sciences companies doing business in the EU need to start getting their data in order and processes in place. In addition to the data requirements of ISO IDMP, the new Target Operating Model (TOM) implies that existing processes within life sciences companies need to be amended to collect more data from an earlier point in the current process.
This report addresses the key factors shaping pharmaceutical formulation, including regulation, QC and analysis.
Access the full report now to discover the techniques, tools and innovations that are transforming pharmaceutical formulation, and learn how to position your organisation for long-term success.
What you’ll discover:
Key trends shaping the pharmaceutical formulation sector
Innovations leading progress in pharmaceutical formulation and how senior professionals can harness their benefits
Considerations and best practices when utilising QbD during formulation of oral solid dosage forms
In the first instance, IDMP compliance will drive better patient outcomes and more efficient processes. Beyond that, it will support new opportunities for sharing data and automation across the regulatory and supply chain divide”
In parallel with the launch of the EU IG version 2 on 22 February, the sector’s response to the pandemic has further highlighted the pressing need for data standards; so that data may be shared to report on supply chain issues, which vaccines are administered to which patients, adverse events and for patient information.
IDMP data standards provide the opportunity to link the regulatory world with the supply chain world. Until now, the supply chain, regulatory, pharmacovigilance and clinical functions might all have used different names for the same products and active substance(s). Now these different worlds will be able to speak the same language; sharing data and terminology that will simplify manufacturing, supply chain and patient information data sharing.
Use cases for structured life sciences data exchange
There are compelling use cases for IDMP structured data exchange across life science organisations, as structured data exchange will support quality assurance by providing the ability to compare registrations across regions using common data standards.
Firstly, regulatory departments will find it more straightforward to generate forms and documents from data. IDMP structured data exchange will help enhance pharmacovigilance processes and improve signal detection of adverse events reported at a global level. Additionally, it will support the generation of electronic product information for patients and healthcare professionals.
The supply chain will gain the possibility to optimise the batch release process and reporting and mitigation of shortages of medicines. IDMP will also make it easier to compare products across countries and regions (ie, evaluating product X in country one against product Y in country two).
Finally, the exchange of structured data can also enable the acceleration of regulatory processes relating to acquisition and disinvestment of parts of the product portfolio.
Improving patient information
EMA’s Master Data Management (SPOR) and TOM will become foundational building blocks for IDMP compliance and optimisation opportunities, such as improving patient information. To implement ISO IDMP standards, EMA developed four domains of master data in pharmaceutical regulatory processes: substance, product, organisation and referential (SPOR) data. Life sciences companies will, in many cases, need to speed up their preparations towards SPOR-readiness. Cross-functional reporting capabilities will allow different departments and systems to share SPOR data.
Focus on process, organisation, technology and information
There are several practical steps companies may take in response to the EU IG, because implementation of ISO IDMP and the TOM on which companies must submit data and documents will affect process, organisation, technology and information.
1. Process. The implementation of EU IG version 2 and the TOM of submitting the data together with documents very much changes the processes pharmaceutical companies have followed for the past decades.
Traditionally, regulatory departments created and submitted documents, not data, to the regulator. In 2012, the industry began submitting some data for Marketing Authorisation Applications (MAAs), but only after the regulatory assessment (xEVMPD). Now, companies need to get ready to submit data at the start of the regulatory activity relating to a new medicine or variation. In addition, that data requirement is not limited to just regulatory data – it may include data from other sources too.
2. Organisation. Awareness of the IDMP changes is likely to vary across departments. Some regulatory departments are well prepared for the implementation requirements, while others are barely aware that change is coming. Management may simply see this as another tiresome and costly compliance overhead.
Raising awareness of the challenges and opportunities is key. Providing training may be appropriate for some people, but for others it may be a matter of creating awareness and getting them to buy into the potential business benefits and opportunities for innovation and efficiencies.
IDMP implementation is not only a regulatory change. While it is tempting for regulatory departments to take ownership of collecting the data, beyond the first iteration, a company-wide approach is best to achieve effective data governance and consistent data throughout the supply chain. For example, the composition of a medicine or vaccine may be recorded differently in systems used by regulatory department and manufacturing as presented in the final patient information leaflet. Ie, if water is being used in the manufacturing process, it may be recorded in the composition by the manufacturer but not in the final patient information leaflet, as the water dissolves during the manufacturing process. Regulatory needs to decide how to handle and track these kinds of inconsistencies as they may lead to issues with the regulator.
3. Technology. Many life sciences companies have regulatory information management (RIM) systems but continue to use manual data entry. Now, RIM systems need to be able to send data direct to the EMA and companies need to collect more data, earlier in the process, with new technology. Yet, implementation of novel software within a short timeframe is challenging as pharma companies must validate the technology to guarantee that it really works as expected. However, it is realistic to believe that in a year’s time there will be tools out there that are validated, implemented and ready.
4. Information. Data and information that companies will be required to produce and share may well be distributed across organisations in many different formats. Bringing centralised RIM data into the IDMP fold is one thing, but locating, extracting and sharing data that is buried in documents across the organisation is a much bigger task. Some companies might have 50 centralised procedures, but 1500 non-centralised procedures that are not addressed by current technology solutions. Manual data collection is not an option at this scale, so technology can help by changing your documents into data. Many pharma companies are implementing technology solutions for centralised procedures first and then turning their attention to non-centralised procedures.
There are a number of challenges and opportunities that come with the EU IG. Compliance with ISO IDMP is more than just a mandatory regulatory exercise – it drives real world improvements in patient outcomes. In the past, the pharma industry accepted delays created by poor data sharing as inevitable, but as the world watches the roll-out of the coronavirus vaccine, unnecessary delay is no longer acceptable. Increasingly, the industry is focusing on getting drugs to patients in a much timelier manner and giving patients better and more accessible information about their medicines.
In the first instance, IDMP compliance will drive better patient outcomes and more efficient processes. Beyond that, it will support new opportunities for sharing data and automation across the regulatory and supply chain divide, accelerating regulatory approval and time to market. It is time to take IDMP compliance off the back burner and act now to create a solid platform for future innovation.
About the author
Remco Munnik is Associate Director at Iperion, a globally-operating life sciences consultancy firm which is paving the way to digital healthcare, by supporting standardisation and ensuring the right technology, systems and processes are in place to enable insightful business decision-making and innovation.
This website uses cookies to enable, optimise and analyse site operations, as well as to provide personalised content and allow you to connect to social media. By clicking "I agree" you consent to the use of cookies for non-essential functions and the related processing of personal data. You can adjust your cookie and associated data processing preferences at any time via our "Cookie Settings". Please view our Cookie Policy to learn more about the use of cookies on our website.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorised as ”Necessary” are stored on your browser as they are as essential for the working of basic functionalities of the website. For our other types of cookies “Advertising & Targeting”, “Analytics” and “Performance”, these help us analyse and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these different types of cookies. But opting out of some of these cookies may have an effect on your browsing experience. You can adjust the available sliders to ‘Enabled’ or ‘Disabled’, then click ‘Save and Accept’. View our Cookie Policy page.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Cookie
Description
cookielawinfo-checkbox-advertising-targeting
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".
cookielawinfo-checkbox-analytics
This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance
This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".
PHPSESSID
This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
zmember_logged
This session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.
Performance cookies are includes cookies that deliver enhanced functionalities of the website, such as caching. These cookies do not store any personal information.
Cookie
Description
cf_ob_info
This cookie is set by Cloudflare content delivery network and, in conjunction with the cookie 'cf_use_ob', is used to determine whether it should continue serving “Always Online” until the cookie expires.
cf_use_ob
This cookie is set by Cloudflare content delivery network and is used to determine whether it should continue serving “Always Online” until the cookie expires.
free_subscription_only
This session cookie is served by our membership/subscription system and controls which types of content you are able to access.
ls_smartpush
This cookie is set by Litespeed Server and allows the server to store settings to help improve performance of the site.
one_signal_sdk_db
This cookie is set by OneSignal push notifications and is used for storing user preferences in connection with their notification permission status.
YSC
This cookie is set by Youtube and is used to track the views of embedded videos.
Analytics cookies collect information about your use of the content, and in combination with previously collected information, are used to measure, understand, and report on your usage of this website.
Cookie
Description
bcookie
This cookie is set by LinkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page.
GPS
This cookie is set by YouTube and registers a unique ID for tracking users based on their geographical location
lang
This cookie is set by LinkedIn and is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
lidc
This cookie is set by LinkedIn and used for routing.
lissc
This cookie is set by LinkedIn share Buttons and ad tags.
vuid
We embed videos from our official Vimeo channel. When you press play, Vimeo will drop third party cookies to enable the video to play and to see how long a viewer has watched the video. This cookie does not track individuals.
wow.anonymousId
This cookie is set by Spotler and tracks an anonymous visitor ID.
wow.schedule
This cookie is set by Spotler and enables it to track the Load Balance Session Queue.
wow.session
This cookie is set by Spotler to track the Internet Information Services (IIS) session state.
wow.utmvalues
This cookie is set by Spotler and stores the UTM values for the session. UTM values are specific text strings that are appended to URLs that allow Communigator to track the URLs and the UTM values when they get clicked on.
_ga
This cookie is set by Google Analytics and is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. It stores information anonymously and assign a randomly generated number to identify unique visitors.
_gat
This cookies is set by Google Universal Analytics to throttle the request rate to limit the collection of data on high traffic sites.
_gid
This cookie is set by Google Analytics and is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.
Advertising and targeting cookies help us provide our visitors with relevant ads and marketing campaigns.
Cookie
Description
advanced_ads_browser_width
This cookie is set by Advanced Ads and measures the browser width.
advanced_ads_page_impressions
This cookie is set by Advanced Ads and measures the number of previous page impressions.
advanced_ads_pro_server_info
This cookie is set by Advanced Ads and sets geo-location, user role and user capabilities. It is used by cache busting in Advanced Ads Pro when the appropriate visitor conditions are used.
advanced_ads_pro_visitor_referrer
This cookie is set by Advanced Ads and sets the referrer URL.
bscookie
This cookie is a browser ID cookie set by LinkedIn share Buttons and ad tags.
IDE
This cookie is set by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
li_sugr
This cookie is set by LinkedIn and is used for tracking.
UserMatchHistory
This cookie is set by Linkedin and is used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences.
VISITOR_INFO1_LIVE
This cookie is set by YouTube. Used to track the information of the embedded YouTube videos on a website.